Showing results (1401-1410 of 1,694) with videos related to

Sort By:
Pageof 170
Oncogene|May 29, 1999
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsM Haber, S B Bordow, J Gilbert, et al.
Global Public Health|June 27, 2020
Translating gene drive science to promote linguistic diversity in community and stakeholder engagementCynthia Cheung, Stephanie Gamez, Rebeca Carballar-Lejarazú, et al.
Plos One|January 10, 2014
Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic miceStephanie M Marshall, Kathryn L Kelley, Matthew A Davis, et al.
Biomaterials Advances|July 31, 2024
Bioactive coatings on 3D printed scaffolds for bone regeneration: Use of Laponite® to deliver BMP-2 in an ovine femoral condyle defect modelKaren M Marshall, Jane S McLaren, Jonathan P Wojciechowski, et al.
Oncotarget|September 14, 2016
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemiaBabasaheb D Yadav, Amy L Samuels, Julia E Wells, et al.
Lancet (London, England)|March 11, 2000
Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trialP L Faris, S W Kim, W H Meller, et al.
The Cochrane Database of Systematic Reviews|May 29, 2026
Interventions for smoking cessation in people undergoing lung cancer screeningHenry M Marshall, Hollie Bendotti, Kylie Morphett, et al.
Thorax|April 24, 2025
Future risk projection to engage 'near-miss' individuals in lung cancer screening eligibility: an analysis of ILST dataChellan Kumarasamy, Kim Betts, Richard Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancerF A Greco, R Figlin, M York, et al.
International Journal of Cancer|February 23, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastomaAndrew E Tee, Olivia C Ciampa, Matthew Wong, et al.
Pageof 170